+499.5%
MRNA vs GNRC
+6.8%
+492.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GNRC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +2.4% | -4.6% | -2.6% |
| 7D | +5.5% | +1.9% | +3.5% | +5.1% |
| 30D | +158.7% | -13.8% | +172.6% | +164.5% |
| 3M | +182.1% | -32.6% | +214.8% | +193.8% |
| 6M | +151.8% | -15.2% | +167.0% | +150.1% |
| YTD | +393.6% | +37.4% | +356.2% | +335.6% |
| 1Y | +499.5% | +5.1% | +494.3% | +451.4% |
| All | +499.5% | +6.8% | +492.7% | +451.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GNRC.
Daily Out/Under-Performance
Portfolio return minus GNRC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GNRC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GNRC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling